Rahul Rama Hegde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rahul Rama Hegde has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Amitava Ghosh
Bengal College of Pharmaceutical Sciences & Research , Durgapur , West Bengal , India
4 shared publications- Anurag Verma
Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh, India
4 shared publications Dilipkumar Pal
B Department of Pharmaceutical Sciences , Guru Ghasidas Vishwavidyalaya (A Central University) , Koni, Bilaspur , CG , India
4 shared publicationsSyed Riaz Hashim
D Department of Chemistry , School of Pharmaceutical Sciences, IFTM University Moradabad , Uttar Pradesh , India
4 shared publications- Priyanka Rani
Assistant Professor PG Department of Shalakya Tantra, Rishikul Campus, U.A.U, Haridwar, Uttarakhand, India
3 shared publications Shiv Sankar Bhattacharya
3 shared publications
Latest Publications
- 3 July 2016
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 28 (4) , 255-265
Acetamides: chemotherapeutic agents for inflammation-associated cancers
Now clear evidences are available to support the hypothesis that inflammation accelerates the conditions including events and molecules that reach to various types of cancers. Inflammation is a normal response to infection containing the innate and adaptive immune systems. However, when allowed to continue, unresolved, perturbation of cellular microenvironment takes place; therefore, it leads to adaptations in genes that are linked to cancer. In addition, a lot of data are accessible confirming the concept that tumour microenvironment is orchestrated by various inflammatory cells and goes to neoplastic process and finally invasion, migration and metastasis. However, infiltrations of leucocytes lead to angiogenesis, propagation and invasion. An inflammatory microenvironment that perhaps fostering impact of angiogenesis include cytokines, chemokines, enzymes and growth factors that play key role for expansion and invasion of cancer cells. This insight highlights the pathogenesis of inflammation-associated cancers and also touches and fosters the role of acetamides for the treatment and chemoprevention of carcinomas that are allied with inflammation.
- 3 July 2016
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 28 (4) , 255-265
Acetamides: chemotherapeutic agents for inflammation-associated cancers
Now clear evidences are available to support the hypothesis that inflammation accelerates the conditions including events and molecules that reach to various types of cancers. Inflammation is a normal response to infection containing the innate and adaptive immune systems. However, when allowed to continue, unresolved, perturbation of cellular microenvironment takes place; therefore, it leads to adaptations in genes that are linked to cancer. In addition, a lot of data are accessible confirming the concept that tumour microenvironment is orchestrated by various inflammatory cells and goes to neoplastic process and finally invasion, migration and metastasis. However, infiltrations of leucocytes lead to angiogenesis, propagation and invasion. An inflammatory microenvironment that perhaps fostering impact of angiogenesis include cytokines, chemokines, enzymes and growth factors that play key role for expansion and invasion of cancer cells. This insight highlights the pathogenesis of inflammation-associated cancers and also touches and fosters the role of acetamides for the treatment and chemoprevention of carcinomas that are allied with inflammation.
- 19 May 2016
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 16 (999) , 1
Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives
- 19 May 2016
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 16 (999) , 1
Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives
- 27 March 2016
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 24 (10) , 897-915
Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems
H. pylori have been subject to intense investigation since its discovery from gastric biopsy in 1982. This gastropathogen has been regarded as serious public health problem due to its association with dyspepsia, gastritis, gastroduodenal ulcers, mucus-associated lymphoid tissue lymphoma and gastric carcinoma. In vivo eradication of established H. pylori infections is difficult due to several factors such as gastric niche, coccoid form due to sub minimum inhibitory concentration of antimicrobials, bacterial load, primary antibiotic resistance, patient compliance and stability of therapeutics in gastric acid secretion. Considering these factors, a logical way to improve the outcome of the treatment is to develop dosage forms which are able to deliver the anti-helicobacter agents in the gastric niche for both local and systemic action, simultaneously taking care of stability of therapeutics in acidic environment. Such dosage forms, which are popularly known as gastro retentive drug delivery systems (GRDDS), have the immense potential to effectively counter the problem of high bacterial load; prevent induction of coccoid bacteria thereby improving treatment outcome and compliance. This review describes efficacy of various therapeutic agents, treatment strategies and status of different GRDDS until now.
- 27 March 2016
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 24 (10) , 897-915
Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems
H. pylori have been subject to intense investigation since its discovery from gastric biopsy in 1982. This gastropathogen has been regarded as serious public health problem due to its association with dyspepsia, gastritis, gastroduodenal ulcers, mucus-associated lymphoid tissue lymphoma and gastric carcinoma. In vivo eradication of established H. pylori infections is difficult due to several factors such as gastric niche, coccoid form due to sub minimum inhibitory concentration of antimicrobials, bacterial load, primary antibiotic resistance, patient compliance and stability of therapeutics in gastric acid secretion. Considering these factors, a logical way to improve the outcome of the treatment is to develop dosage forms which are able to deliver the anti-helicobacter agents in the gastric niche for both local and systemic action, simultaneously taking care of stability of therapeutics in acidic environment. Such dosage forms, which are popularly known as gastro retentive drug delivery systems (GRDDS), have the immense potential to effectively counter the problem of high bacterial load; prevent induction of coccoid bacteria thereby improving treatment outcome and compliance. This review describes efficacy of various therapeutic agents, treatment strategies and status of different GRDDS until now.
- 1 February 2016
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 31, 53-64
Tailored-interpenetrating polymer network beads of κ-carrageenan and sodium carboxymethyl cellulose for controlled drug delivery
- 1 February 2016
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 31, 53-64
Tailored-interpenetrating polymer network beads of κ-carrageenan and sodium carboxymethyl cellulose for controlled drug delivery
- 1 January 2016
- Vol. 16 (7)
Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives.
- 1 January 2016
- Vol. 16 (7)
Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives.
- Open Access
- 1 January 2015
- Published by National Library of Serbia
- Vol. 69 (4) , 405-415
Synthesis, characterization and pharmacological evaluation of substituted phenoxy acetamide derivatives
A novel series of 2-(substituted phenoxy)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)acetamide and N-(2-bromocyclohexyl)-2-(substituted phenoxy)acetamide derivatives having cyclohexyl nucleus as common in both types were synthesized and assessed for their anti-inflammatory activity by a carrageenan induced rat paw oedema method, analgesic activity by Eddy?s hot plate method and antipyretic activity by brewer?s yeast induced pyrexia method. All the novel derivatives have been synthesized by the reaction of camphor and similar ketone having cyclohexane nucleus (e.g. 2-bromocyclohexanone) with ammonium carbonate and formic acid resulting in the formation of aromatic amines (1a-b). These amines on further chloroacetylation with chloroacetylchloride give compounds (2a-b). Compounds (2a-b) are converted to 2-(substituted phenoxy)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl) acetamide and N-(2-bromocyclohexyl)-2-(substituted phenoxy)acetamide derivatives on treatment with substituted phenol. Among the series 3a-f, 3i, 3k, 3l compounds showed significant anti-inflammatory activity as compared to the standard drug diclofenac sodium and also compound 3a-f, 3h, 3j, 3k exhibit significant analgesic activity as compared to the standard drug. Compounds 3a-f and 3k showed antipyretic activity nearly to the standard drug indomethacin. Compounds 3a-f and 3k possess anti-inflammatory, analgesic and antipyretic activities near to the standard.
- 1 January 2015
- Published by National Library of Serbia
- Vol. 69 (4) , 405-415
Open AccessSynthesis, characterization and pharmacological evaluation of substituted phenoxy acetamide derivatives
A novel series of 2-(substituted phenoxy)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)acetamide and N-(2-bromocyclohexyl)-2-(substituted phenoxy)acetamide derivatives having cyclohexyl nucleus as common in both types were synthesized and assessed for their anti-inflammatory activity by a carrageenan induced rat paw oedema method, analgesic activity by Eddy?s hot plate method and antipyretic activity by brewer?s yeast induced pyrexia method. All the novel derivatives have been synthesized by the reaction of camphor and similar ketone having cyclohexane nucleus (e.g. 2-bromocyclohexanone) with ammonium carbonate and formic acid resulting in the formation of aromatic amines (1a-b). These amines on further chloroacetylation with chloroacetylchloride give compounds (2a-b). Compounds (2a-b) are converted to 2-(substituted phenoxy)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl) acetamide and N-(2-bromocyclohexyl)-2-(substituted phenoxy)acetamide derivatives on treatment with substituted phenol. Among the series 3a-f, 3i, 3k, 3l compounds showed significant anti-inflammatory activity as compared to the standard drug diclofenac sodium and also compound 3a-f, 3h, 3j, 3k exhibit significant analgesic activity as compared to the standard drug. Compounds 3a-f and 3k showed antipyretic activity nearly to the standard drug indomethacin. Compounds 3a-f and 3k possess anti-inflammatory, analgesic and antipyretic activities near to the standard.
- Open Access
- 14 August 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-9
Anticancer, Anti-Inflammatory, and Analgesic Activities of Synthesized 2-(Substituted phenoxy) Acetamide Derivatives
The aphorism was to develop new chemical entities as potential anticancer, anti-inflammatory, and analgesic agents. The Leuckart synthetic pathway was utilized in development of novel series of 2-(substituted phenoxy)-N-(1-phenylethyl)acetamide derivatives. The compounds containing 1-phenylethylamine as basic moiety attached to substituted phenols were assessed for their anticancer activity against MCF-7 (breast cancer), SK-N-SH (neuroblastoma), anti-inflammatory activity, and analgesic activity. These investigations revealed that synthesized products3a–jwith halogens on the aromatic ring favors as the anticancer and anti-inflammatory activity. Among all, compound3cN-(1-(4-chlorophenyl)ethyl)-2-(4-nitrophenoxy)acetamide exhibited anticancer, anti-inflammatory, and analgesic activities. In conclusion,3cmay have potential to be developed into a therapeutic agent.
- 14 August 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-9
Open AccessAnticancer, Anti-Inflammatory, and Analgesic Activities of Synthesized 2-(Substituted phenoxy) Acetamide Derivatives
The aphorism was to develop new chemical entities as potential anticancer, anti-inflammatory, and analgesic agents. The Leuckart synthetic pathway was utilized in development of novel series of 2-(substituted phenoxy)-N-(1-phenylethyl)acetamide derivatives. The compounds containing 1-phenylethylamine as basic moiety attached to substituted phenols were assessed for their anticancer activity against MCF-7 (breast cancer), SK-N-SH (neuroblastoma), anti-inflammatory activity, and analgesic activity. These investigations revealed that synthesized products3a–jwith halogens on the aromatic ring favors as the anticancer and anti-inflammatory activity. Among all, compound3cN-(1-(4-chlorophenyl)ethyl)-2-(4-nitrophenoxy)acetamide exhibited anticancer, anti-inflammatory, and analgesic activities. In conclusion,3cmay have potential to be developed into a therapeutic agent.
- 14 May 2014
- Published by Taylor & Francis in Journal of Dispersion Science and Technology
- Vol. 35 (6) , 783-788
Small-Angle Neutron Scattering Study of Nonionic Surfactant Micelles and Phase Transitions in w/o Microemulsion
The structure of micelles formed by a four component water-in-oil nonionic microemulsion surfactant polyoxyethene (20) sorbitan monoleate (Tween 80), sorbitan monolaurate (Span 20) at ethyl oleate and deuterated water interface have been probed by small-angle neutron scattering (SANS). The total surfactant concentration in each of the samples studied (Tween 80: Span 20) is fixed at 3:2. The deuterated water content is variable at 5–60% w/w. The experimental SANS data from all the seven samples are fit well by spherical micelles interacting with hard sphere potential. Increased deuterated water leads to spherical to lamellar and rod-like micelle geometry featured in the SANS scattering data. The observed change in micelle geometry supports the characterization of phase transition between the self-assembled micelles of the nonionic microemulsion.
- 14 May 2014
- Published by Taylor & Francis in Journal of Dispersion Science and Technology
- Vol. 35 (6) , 783-788
Small-Angle Neutron Scattering Study of Nonionic Surfactant Micelles and Phase Transitions in w/o Microemulsion
The structure of micelles formed by a four component water-in-oil nonionic microemulsion surfactant polyoxyethene (20) sorbitan monoleate (Tween 80), sorbitan monolaurate (Span 20) at ethyl oleate and deuterated water interface have been probed by small-angle neutron scattering (SANS). The total surfactant concentration in each of the samples studied (Tween 80: Span 20) is fixed at 3:2. The deuterated water content is variable at 5–60% w/w. The experimental SANS data from all the seven samples are fit well by spherical micelles interacting with hard sphere potential. Increased deuterated water leads to spherical to lamellar and rod-like micelle geometry featured in the SANS scattering data. The observed change in micelle geometry supports the characterization of phase transition between the self-assembled micelles of the nonionic microemulsion.
- 1 December 2013
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 112, 483-491
Tranexamic acid loaded gellan gum-based polymeric microbeads for controlled release: In vitro and in vivo assessment
- 1 December 2013
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 112, 483-491
Tranexamic acid loaded gellan gum-based polymeric microbeads for controlled release: In vitro and in vivo assessment
- 27 September 2013
- Published by Taylor & Francis in Current Eye Research
- Vol. 39 (2) , 155-163
Physicochemical and Pharmacological Investigation of Water/Oil Microemulsion of Non-Selective Beta Blocker for Treatment of Glaucoma
Purpose: Ocular drug delivery system always remained associated with lots of difficulties and faced issues of poor drug absorption and poor bioavailability. Timolol maleate is a nonspecific beta blocker used for reduction of elevated intraocular pressure in glaucoma. Timolol maleate is absorbed systemically and is contraindicated in asthmatic patients. This study is focused to deliver Timolol maleate by a water/oil microemulsion to extend the time of reduced intraocular pressure of glaucomatous rabbit’s eye measured by using a schoetz tonometer. Methods: The microemulsion is prepared by mixing the oily components with two nonionic surfactants, drug and water, and evaluated for the physicochemical, in vitro and in vivo parameters. Results: The colloidal system demonstrates monodisperse distribution behavior and exhibits a uniform size distribution of finite width. In vitro drug release from microemulsion was found to follow Higuchi’s pattern followed by a zero-order drug release by the emulsion. Ex vivo permeation through goat cornea revealed delayed release of Timolol maleate from microemulsion as compared with its aqueous solution. A reduction in intraocular pressure is seen lasting for 12 h compared to aqueous eye drop that lasted for only 5 h. Conclusion. In vivo reduction of intraocular pressure revealed a similar efficacy for once daily dosed 0.3% Timolol maleate in microemulsion formulation compared to 0.5% concentration in both microemulsion as well as aqueous formulation. The possible outcome of dose reduction will reduce the cardiovascular side effects generally reported with Timolol maleate eye drops.
- 27 September 2013
- Published by Taylor & Francis in Current Eye Research
- Vol. 39 (2) , 155-163
Physicochemical and Pharmacological Investigation of Water/Oil Microemulsion of Non-Selective Beta Blocker for Treatment of Glaucoma
Purpose: Ocular drug delivery system always remained associated with lots of difficulties and faced issues of poor drug absorption and poor bioavailability. Timolol maleate is a nonspecific beta blocker used for reduction of elevated intraocular pressure in glaucoma. Timolol maleate is absorbed systemically and is contraindicated in asthmatic patients. This study is focused to deliver Timolol maleate by a water/oil microemulsion to extend the time of reduced intraocular pressure of glaucomatous rabbit’s eye measured by using a schoetz tonometer. Methods: The microemulsion is prepared by mixing the oily components with two nonionic surfactants, drug and water, and evaluated for the physicochemical, in vitro and in vivo parameters. Results: The colloidal system demonstrates monodisperse distribution behavior and exhibits a uniform size distribution of finite width. In vitro drug release from microemulsion was found to follow Higuchi’s pattern followed by a zero-order drug release by the emulsion. Ex vivo permeation through goat cornea revealed delayed release of Timolol maleate from microemulsion as compared with its aqueous solution. A reduction in intraocular pressure is seen lasting for 12 h compared to aqueous eye drop that lasted for only 5 h. Conclusion. In vivo reduction of intraocular pressure revealed a similar efficacy for once daily dosed 0.3% Timolol maleate in microemulsion formulation compared to 0.5% concentration in both microemulsion as well as aqueous formulation. The possible outcome of dose reduction will reduce the cardiovascular side effects generally reported with Timolol maleate eye drops.